February 6th 2025
COUR Pharmaceuticals is about begin a phase 1b/2a study to assess a therapy for type 1 diabetes that prevents islet cell destruction and triggers a T cell response.
New Study to Explore Impact of Type 1 Diabetes on Children's Brain Development
December 2nd 2024A new nationwide study led by the Keck School of Medicine of USC aims to examine how type 1 diabetes impacts children's brain development and cognitive function, focusing on diverse participants and paving the way for early interventions and better diabetes management.
Read More
Comparing and Contrasting Continuous Glucose Monitors and Insulin Pumps
October 31st 2024The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in type 1 diabetes treatment, according to David Maahs, M.D., M.A., Ph.D., from Stanford University.
Read More
Study Finds More than 20% of Children with Medicaid Receive Metformin for Type 1 Diabetes
August 5th 2024Medicaid children with type 1 diabetes are three times more likely to receive metformin than commercial enrollees even though metformin is only indicated for use in patients with type 2 diabetes.
Read More
Unintended Effects of Caps on Insulin Out-of-Pocket Costs
March 28th 2024People with higher incomes and those in health plans with health savings accounts benefit more than others, according to research results published this week in the Annals of Internal Medicine. The research also showed no increase in insulin use,
Read More